共 174 条
[1]
Rybak MJ(2006)The pharmacokinetic and pharmacodynamic properties of vancomycin Clin Infect Dis. 42 S35-S39
[2]
Álvarez R(2016)Optimizing the clinical use of vancomycin Antimicrob Agents Chemother. 60 2601-2609
[3]
López Cortés LE(2011)Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children Clinical Infectious Diseases 52 e18-e55
[4]
Molina J(2015)Paediatric pharmacokinetics: key considerations Br J Clin Pharmacol. 79 395-404
[5]
Cisneros JM(2019)Augmented renal clearance: a common condition in critically ill children Pediatric Nephrology 34 1099-1106
[6]
Pachón J(2015)Clearance Trans Clin Pharmacol. 23 42-45
[7]
Liu Catherine(2012)Augmented renal clearance in septic patients and implications for vancomycin optimisation Int J Antimicrob Agents. 39 420-423
[8]
Bayer Arnold(2015)Factors impacting unbound vancomycin concentrations in different patient populations Antimicrob Agents Chemother. 59 7073-7079
[9]
Cosgrove Sara E.(2017)Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study Acta Anaesthesiol Scand. 61 627-635
[10]
Daum Robert S.(2014)Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study Crit Care. 18 R99-24